MARKET

AGE

AGE

AgeX Therapeutics
AMEX

Real-time Quotes | Nasdaq Last Sale

1.780
-0.040
-2.20%
Closed 14:44 11/27 EST
OPEN
1.890
PREV CLOSE
1.820
HIGH
1.890
LOW
1.720
VOLUME
149.49K
TURNOVER
--
52 WEEK HIGH
3.930
52 WEEK LOW
0.6660
MARKET CAP
67.09M
P/E (TTM)
-6.0217
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Where Do Hedge Funds Stand On AgeX Therapeutics, Inc. (AGE)?
Is AgeX Therapeutics, Inc. (NYSE:AGE) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial expertise to […]
Insider Monkey · 2d ago
Medigus, Altimmune leads healthcare gainers; Gossamer Bio, Avenue Therapeutics among major losers
Gainers: Medigus (MDGS) +84%, Altimmune (ALT) +25%, Enlivex Therapeutics (ENLV) +16%, BiondVax Pharmaceuticals (BVXV) +16%, Aileron Therapeutics (ALRN) +15%.Losers: Gossamer Bio (GOSS) -34%, Avenue Therapeutics (ATXI) -17%, Emergent BioSolutions (EBS) -13%, AgeX Therapeutics (AGE) -9%, Inozyme Pharma (INZY) -7%.
Seekingalpha · 10/13 15:06
DDS, WIMI, SOL and FBIO among midday movers
Gainers: iHuman (IH) +44%.Dillard's (DDS) +37%.Acorn International (ATV) +36%.Wah Fu Education (WAFU) +29%.Lizhi (LIZI) +29%.Apex Global Brands (APEX) +25%.WiMi Hologram Cloud (WIMI) +25%.Surface Oncology (SURF) +19%.Skillful Craftsman Education Technology (EDTK) +16%.Reliv'
Seekingalpha · 10/12 16:45
Organovo Holdings, Lantern Pharma leads healthcare gainers, Fortress Biotech, Zynex among major losers
Gainers: Organovo Holdings (ONVO) +12%, Lantern Pharma (LTRN) +11%, Cancer Genetics (CGIX) +10%, American Well (AMWL) +10%, Immuron (IMRN) +9%.Losers: Avenue Therapeutics (ATXI) -57%, Zynex (ZYXI) -27%, Fortress Biotech (FBIO) -22%,  AgeX Therapeutics (AGE) -12%, Vaccinex (VCNX) -11%.
Seekingalpha · 10/12 14:58
PG&E, Vedanta leads premarket losers' pack
Avenue Therapeutics (ATXI) -55% on FDA response letter regarding its IV tramadol marketing application to treat patients in acute pain who require an opioid.Fortress Biotech (FBIO) -30%.ReneSola (SOL) -7% on $5M registered direct offering.VivoPower
Seekingalpha · 10/12 12:34
PGEN, ACRX, MNK and FTV among midday movers
Gainers: Sanchez Midstream Partners (SNMP) +124%.VivoPower International (VVPR) +92%.SpartanNash (SPTN) +34%.Precigen (PGEN) +29%.India Globalization Capital (IGC) +26%.Marine Petroleum Trust (MARPS) +25%.Just Energy (JE) +23%.cbdMD (YCBD) +22%.Medigus (MDGS) +21%.AcelRx Pharmaceuticals (ACRX) +17%.Losers: ShiftPixy (PIXY) -25%.Camber Energy
Seekingalpha · 10/09 16:38
Mid-Day Market Update: Gold Gains 2%; ShiftPixy Shares Plunge
Midway through trading Friday, the Dow traded up 0.44% to 28549.53 while the NASDAQ rose 0.99% to 11534.04. The S&P also rose, gaining 0.59% to 3467.29.
Benzinga · 10/09 16:15
Precigen and Medigus lead Healthcare gainers; Mallinckrodt and GeoVax Labs lead losers
Gainers: Precigen (PGEN) +26%. Medigus (MDGS) +24%. Aclaris Therapeutics (ACRS) +17%. cbdMD (YCBD) +15%. Abeona Therapeutics (ABEO) +12%.Losers: Mallinckrodt (MNK) -18%. GeoVax Labs (GOVX) -13%. AgeX Therapeutics (AGE) -12%. COMPASS Pathways (CMPS) -9%. ThermoGenesis (THMO) -8%.
Seekingalpha · 10/09 15:01
More
Forecast
EPSBVPSCFPS
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AGE. Analyze the recent business situations of AgeX Therapeutics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Institutional Holdings
Institutions: 54
Institutional Holdings: 6.40M
% Owned: 16.98%
Shares Outstanding: 37.69M
TypeInstitutionsShares
Increased
21
998.73K
New
9
146.44K
Decreased
7
89.35K
Sold Out
14
763.59K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+3.18%
Pharmaceuticals & Medical Research
+1.72%
Key Executives
Non-Executive Chairman/Independent Director
Gregory Bailey
Chief Executive Officer/Founder/Director
Michael West
Chief Financial Officer
Andrea Park
Chief Operating Officer
Nafees Malik
Vice President - Research & Development
Hal Sternberg
Independent Director
Annalisa Jenkins
Independent Director
Michael May
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About AGE
AgeX Therapeutics Inc. is a biotechnology company. The Company is focused on the development and commercialization of therapeutics targeting human aging. Its induced Tissue Regeneration (iTR) technology is based telomerase-mediated cellular immortality and regenerative biology. Its pipeline includes two cell-based, two drug-based therapeutic products, online database products and research products. The Company’s AGEX-BAT1 is its cell therapy product candidate that is being developed for the treatment of certain age-related metabolic disorders, such as Type II (adult-onset) diabetes. AGEX-VASC1 is its cell-based therapy that is designed to restore vascular support in aged ischemic tissues such as the aging heart. AGEX-iTR1547 is its drug-based formulation developed to restore regenerative potential in an array of aged tissues afflicted with degenerative disease using its proprietary iTR technology. Renelon is its iTR product candidate designed to promote scar less tissue repair.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of AgeX Therapeutics Inc stock information, including AMEX:AGE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AGE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AGE stock methods without spending real money on the virtual paper trading platform.